RBPJ and isolated hemihyperplasia: Matching the treatment group with age at surgery revealed no significant differences in the number of SOX18+, RBPJ+, or SOX18+RBPJ+ cells in the age-matched cohort of 13 IH specimens from patients who received no pharmacologic therapy and 13 IH specimens from patients who received propranolol therapy (Supplemental Figure 6).